|
US10844435B1
|
|
Method to treat hypotension using vasopressin in certain genotypes
|
|
US2018222652A1
|
|
Article for storage of thin-film drug
|
|
US2017290881A1
|
|
Vasopressin formulations for use in treatment of hypotension
|
|
US2017290880A1
|
|
Vasopressin formulations for use in treatment of hypotension
|
|
US2017189352A1
|
|
Epinephrine formulations
|
|
US2017157202A1
|
|
Vasopressin formulations for use in treatment of hypotension
|
|
US2017157203A1
|
|
Vasopressin formulations for use in treatment of hypotension
|
|
US2017035853A1
|
|
Vasopressin formulations for use in treatment of hypotension
|
|
US2015272876A1
|
|
Vitamin B12 nasal spray and method of use
|
|
JP2015180676A
|
|
Cyanocobalamine low-viscosity aqueous formulation for intranasal delivery
|
|
US9375478B1
|
|
Vasopressin formulations for use in treatment of hypotension
|
|
US9119876B1
|
|
Epinephrine formulations
|
|
AU2014202415A1
|
|
Cyanocobalamin low viscosity aqueous formulations for intranasal delivery
|
|
JP2013227319A
|
|
Cyanocobalamin low viscosity aqueous formulation for intranasal delivery
|
|
US2009186086A1
|
|
Solid multilayer oral dosage forms
|
|
US2008014257A1
|
|
Oral dosage forms
|
|
CA2863377A1
|
|
Cyanocobalamin low viscosity aqueous formulations for intranasal delivery
|
|
KR20140101010A
|
|
Cyanocobalamin low viscosity aqueous formulations for intranasal delivery
|
|
WO2006020111A1
|
|
Formulation stabilizer for proton pump inhibitors
|
|
US2006293863A1
|
|
System and method for sorting data
|
